BWAY BrainsWay Ltd.
Healthcare$15.89+5.23%ClosedMarket Cap: $623.3M
As of 2026-05-26
Valuation
P/E (TTM)
71.36
PEG
0.44
P/B
8.12
P/S
10.67
EV/EBITDA
81.45
DCF Value
$-14.38
FCF Yield
1.7%
Div Yield
0.0%
Margins & Returns
Gross Margin
75.5%
Operating Margin
10.1%
Net Margin
14.6%
ROE
12.3%
ROA
7.5%
ROIC
6.4%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $15.5M | 75.2% | $2.0M | $2.3M | $— | — |
| Q4 null | $14.5M | 76.4% | $1.9M | $2.9M | $— | — |
| FY null | $52.2M | 75.4% | $4.3M | $7.6M | $— | — |
| Q3 null | $13.5M | 75.2% | $1.3M | $1.6M | $— | — |
| Q2 null | $12.6M | 75.2% | $578.0K | $2.0M | $— | — |
| Q1 null | $11.5M | 74.6% | $576.0K | $1.1M | $— | — |
| Q4 null | $11.4M | 74.6% | $431.0K | $1.5M | $— | — |
| FY null | $41.0M | 74.6% | $1.4M | $2.9M | $— | — |
| Q3 null | $10.5M | 73.5% | $281.0K | $662.0K | $— | — |
| Q2 null | $10.0M | 75.3% | $586.0K | $600.0K | $— | — |
| Q1 null | $9.1M | 74.9% | $93.0K | $111.0K | $— | — |
| Q4 2023 | $9.0M | 74.6% | $10.1M | $127.0K | $0.00 | — |